United States Rejects WHO’s Pandemic Response Pact
Global Health Governance Faces Setback as US Withdraws Support
The United States has formally rejected the World Health Organization’s pandemic preparedness accord, which aimed to ensure equitable access to vaccines, medicines, and diagnostics during future pandemics. The decision reflects U.S. concerns over sovereignty, WHO authority, and vague language in the agreement.

U.S. Rejection of WHO Agreement: Implications for Global Health
- The U.S. government has officially rejected the legally binding global pandemic accord adopted by the World Health Organization (WHO) in May 2025.
- The decision was announced jointly by the State Department and Department of Health and Human Services, highlighting a unified stance on the issue.
- The accord was a result of three years of negotiation following global failures during the COVID-19 pandemic, which exposed inequities in global health response.
- U.S. negotiators disengaged from discussions earlier, stemming from a withdrawal initiated under President Donald Trump’s administration, reflecting ongoing skepticism towards international health governance.
- The rejection means the U.S. is not obligated to follow the pact’s terms, potentially impacting global pandemic preparedness efforts.
Concerns Over WHO Authority and Transparency
- The U.S. statement criticized the 2024 amendments for vague and broad terminology, which could lead to misinterpretation and overreach.
- It expressed concern that WHO responses might focus on “political issues like solidarity” over effective emergency action, potentially compromising rapid response capabilities.
- The accord gives WHO more power in declaring pandemics and coordinating global health responses, which the U.S. views as a potential infringement on national decision-making.
- The U.S. also claimed the agreement was developed without adequate public consultation, raising questions about transparency in international health policy-making.
- Senator Marco Rubio and Robert F. Kennedy Jr. led the opposition, citing risks to national sovereignty and the need for more localized control in health emergencies.
| WHO Pandemic Accord – Key Features |
| ● The WHO accord mandates equitable access to vaccines, therapeutics, and diagnostics during pandemics, aiming to prevent disparities seen during COVID-19. |
| ● 20% of health commodities from participating countries are to be allocated to WHO for global distribution, ensuring resources reach nations in need. |
| ● It aims to prevent a repeat of COVID-19 disparities, where poorer nations struggled for resources while wealthier countries secured supplies. |
| ● Emphasizes international cooperation, solidarity, and data sharing among member states to enhance global pandemic response capabilities. |
| ● Though non-binding for non-signatories like the U.S., the pact sets a global health governance framework for future emergencies, potentially |